Pandey AV - Search Results

1

Pharmacogenomics of human P450 oxidoreductase.

Pandey AV, Sproll P. Pandey AV, et al. Front Pharmacol. 2014 May 9;5:103. doi: 10.3389/fphar.2014.00103. eCollection 2014. Front Pharmacol. 2014. PMID: 24847272 Free PMC article. Review.

2

Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase.

Pandey AV, Kempná P, Hofer G, Mullis PE, Flück CE. Pandey AV, et al. Mol Endocrinol. 2007 Oct;21(10):2579-95. doi: 10.1210/me.2007-0245. Epub 2007 Jun 26. Mol Endocrinol. 2007. PMID: 17595315

3

Clinical, structural and functional implications of mutations and polymorphisms in human NADPH P450 oxidoreductase.

Flück CE, Nicolo C, Pandey AV. Flück CE, et al. Among authors: pandey av. Fundam Clin Pharmacol. 2007 Aug;21(4):399-410. doi: 10.1111/j.1472-8206.2007.00520.x. Fundam Clin Pharmacol. 2007. PMID: 17635179 Review.

4

P450 oxidoreductase deficiency - a new form of congenital adrenal hyperplasia.

Flück CE, Pandey AV, Huang N, Agrawal V, Miller WL. Flück CE, et al. Among authors: pandey av. Endocr Dev. 2008;13:67-81. doi: 10.1159/000134826. Endocr Dev. 2008. PMID: 18493134 Review.

5

Modeling of human P450 oxidoreductase structure by in silico mutagenesis and MD simulation.

Flück CE, Mullis PE, Pandey AV. Flück CE, et al. Among authors: pandey av. Mol Cell Endocrinol. 2009 Dec 10;313(1-2):17-22. doi: 10.1016/j.mce.2009.09.001. Epub 2009 Sep 8. Mol Cell Endocrinol. 2009. PMID: 19744540

6

Reduction in hepatic drug metabolizing CYP3A4 activities caused by P450 oxidoreductase mutations identified in patients with disordered steroid metabolism.

Flück CE, Mullis PE, Pandey AV. Flück CE, et al. Among authors: pandey av. Biochem Biophys Res Commun. 2010 Oct 8;401(1):149-53. doi: 10.1016/j.bbrc.2010.09.035. Epub 2010 Sep 16. Biochem Biophys Res Commun. 2010. PMID: 20849814

7

Deletion of P399_E401 in NADPH cytochrome P450 oxidoreductase results in partial mixed oxidase deficiency.

Flück CE, Mallet D, Hofer G, Samara-Boustani D, Leger J, Polak M, Morel Y, Pandey AV. Flück CE, et al. Among authors: pandey av. Biochem Biophys Res Commun. 2011 Sep 9;412(4):572-7. doi: 10.1016/j.bbrc.2011.08.001. Epub 2011 Aug 6. Biochem Biophys Res Commun. 2011. PMID: 21843508

8

NADPH P450 oxidoreductase: structure, function, and pathology of diseases.

Pandey AV, Flück CE. Pandey AV, et al. Pharmacol Ther. 2013 May;138(2):229-54. doi: 10.1016/j.pharmthera.2013.01.010. Epub 2013 Jan 24. Pharmacol Ther. 2013. PMID: 23353702 Review.

9

Impact on CYP19A1 activity by mutations in NADPH cytochrome P450 oxidoreductase.

Flück CE, Pandey AV. Flück CE, et al. Among authors: pandey av. J Steroid Biochem Mol Biol. 2017 Jan;165(Pt A):64-70. doi: 10.1016/j.jsbmb.2016.03.031. Epub 2016 Mar 23. J Steroid Biochem Mol Biol. 2017. PMID: 27032764

10

P450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms.

Burkhard FZ, Parween S, Udhane SS, Flück CE, Pandey AV. Burkhard FZ, et al. Among authors: pandey av. J Steroid Biochem Mol Biol. 2017 Jan;165(Pt A):38-50. doi: 10.1016/j.jsbmb.2016.04.003. Epub 2016 Apr 8. J Steroid Biochem Mol Biol. 2017. PMID: 27068427

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

96 results

Search Page